GRAALL2014
Phase 2 other active
Quick answer
GRAALL2014 for Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years) is a Phase 2 program (other) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
- Phase
- Phase 2
- Modality
- other
- Status
- active